PubMed · 11511216
Insulin-enhancing vanadium(III) complexes.
Abstract
Simple, high-yield, large-scale syntheses of the V(III) complexes tris(maltolato)vanadium(III), V(ma)3, tris(ethylmaltolato)vanadium(III), V(ema)3, tris(kojato)vanadium(III) monohydrate, V(koj)3-H2O, and tris(1,2-dimethyl-3-hydroxy-4-pyridinonato)vanadium(III) dodecahydrate, V(dpp)3-12H2O, are described; the characterization of these complexes by various methods and, in the case of V(dpp)3-12H2O, by an X-ray crystal structure determination, is reported. The ability of these complexes to normalize glucose levels in the STZ-diabetic rat model has been examined and compared with that of the benchmark compound BMOV (bis(maltolato)oxovanadium(IV)), an established insulin-enhancing agent.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Melchior, S J Rettig, B D Liboiron, K H Thompson, V G Yuen, J H McNeill, C Orvig. 2001-08-27. Insulin-enhancing vanadium(III) complexes.. https://doi.org/10.1021/ic000984t. https://searchpubmed.org/record/pubmed%3A11511216/insulin-enhancing-vanadium-iii-complexes
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.